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Pseudomonas aeruginosa is an opportunistic pathogen and is associated with
nosocomial infections. Its ability to thrive in a broad range of environments is due to
a large and diverse genome of which its accessory genome is part. The objective of this
study was to characterize P. aeruginosa strains isolated from children who developed
bacteremia, using pulse-field gel electrophoresis, and in terms of its genomic islands,
virulence genes, multilocus sequence type, and antimicrobial susceptibility. Our results
showed that P. aeruginosa strains presented the seven virulence genes: toxA, lasB,
lecA, algR, plcH, phzA1, and toxR, a type IV pilin alleles (TFP) group I or II. Additionally,
we detected a novel pilin and accessory gene, expanding the number of TFP alleles
to group VI. All strains presented the PAPI-2 Island and the majority were exoU+ and
exoS+ genotype. Ten percent of the strains were multi-drug resistant phenotype, 18%
extensively drug-resistant, 68% moderately resistant and only 3% were susceptible to
all the antimicrobial tested. The most prevalent acquired β-Lactamase was KPC. We
identified a group of ST309 strains, as a potential high risk clone. Our finding also showed
that the strains isolated from patients with bacteremia have important virulence factors
involved in colonization and dissemination as: a TFP group I or II; the presence of the
exoU gene within the PAPI-2 island and the presence of the exoS gene.
Keywords: Pseudomonas aeruginosa, exoS and exoU genes, genomics island, TFP alleles, ST309, bacteremia,
children
INTRODUCTION
Pseudomonas aeruginosa is a Gram-negative bacterium, which is categorized as an opportunistic
pathogen due to its ability to cause infections mainly in immunocompromised patients. It is a
ubiquitous microorganism, metabolically versatile, which is able to adapt to many environments
(Gilligan, 1995; Lyczak et al., 2000). An important virulent characteristic is the formation of
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biofilms and its natural multiresistance to a wide range of
antibiotics and disinfectants (Drenkard and Ausubel, 2002;
Wolska and Szweda, 2009; Poole, 2011; Rybtke et al., 2015). This
microorganism has been associated with nosocomial infections
and outbreaks in Intensive Care Units (ICU) for adults, children
and neonates (Thuong et al., 2003; Agodi et al., 2007; Zhang
et al., 2012). It is a microorganism with the capacity to colonize
different surfaces and in hospitals this is common in the
colonization of humid sources, such as air conditioning units,
sink faucets, and medical equipment (automatic ventilators and
humidifiers; Agodi et al., 2007; Kerr and Snelling, 2009).
Approximately, a 30% of the general population carries P.
aeruginosa on their skin and in their mucosa and intestine
(Thuong et al., 2003; Agodi et al., 2007). This bacterium is
associated with chronic recurrent infections in patients with
cystic fibrosis and it represents a high mortality in children
with underlying conditions such as hemato-oncology diseases,
cardiovascular surgeries, extended hospitalization in the ICU,
gastrointestinal malformations, and prematurity (Fergie et al.,
1994; Zhang et al., 2012). Some reports have shown that the
incidence of bacteremia due to P. aeruginosa falls between 0.09
and 3.8 cases per 1,000 patients with a greater frequency in
boys (Grisaru-Soen et al., 2000) with underlying conditions, such
as hemato-oncological diseases. Nonetheless, P. aeruginosa also
causes infections, such as ear infections or skin infections in
healthy people exposed to poorly chlorinated water in swimming
pools or tubs for hydromassage (Mena and Gerba, 2009; Rybtke
et al., 2015).
The genome of P. aeruginosa is highly variable due to the
insertion of different mobile elements, such as genomic and
pathogenic islands that contribute to chromosomal organization
and genetic content thereby providing versatility to the bacteria
that allows for better adaptation to different niches (Shen et al.,
2006; Wiehlmann et al., 2007). Horizontal gene transfer (HGT) is
a major force in bacterial evolution conferring a great variability
between the species (Jolley and Maiden, 2010; Darmon and
Leach, 2014).
The majority of the studies related to P. aeruginosa and
pediatric cohorts have been performed in patients with cystic
fibrosis (Cf; Kus et al., 2004; Kidd et al., 2015), which have genetic
and phenotypic characteristic well-studied. The distribution of
pilin alleles amongst CF human isolates belong to pilin group
I. Biofilm production is thought to be a hallmark of chronic
colonization of the CF lung; P. aeruginosa “hypermutators”
can be isolated from 37 to 54% of the patients with chronic
CF infections. MutS, a critical component of the mismatch
repair system, is commonly lost in hypermutator strains,
resulting in elevated mutation rates. P. aeruginosa hypermutator
strains isolated from chronically infected patients are often
more resistant to antibiotics, possess a mucoid phenotype with
small-colony variants on culture medium, and lose both the
lipopolysaccharide (LPS) O-antigen and motility (Deretic et al.,
1994; Mahenthiralingam et al., 1994; Govan and Deretic, 1996;
Häußler et al., 1999, 2003; Oliver et al., 2000; Leone et al.,
2008; Chung et al., 2012; Kidd et al., 2012; Rybtke et al.,
2015). Published data show the importance of P. aeruginosa
as a cause of bacteremia in patients who develop neutropenia
following chemotherapy and the bacterium has been associated
with nosocomial infections (Pronovost et al., 2006). However,
there is little published data on the genetic characteristics and
the susceptibility patterns of P. aeruginosa strains isolated from
blood samples from children who developed bacteremia and/or
neutropenia following chemotherapy (Oliver et al., 2015; Peña
et al., 2015). In the present study, we characterized a collection of
P. aeruginosa strains isolated from the blood of 60 children with a
background of underlying conditions that developed bacteremia
and neutropenia post-chemotherapy in a highly specialized
hospital in Mexico City.
MATERIALS AND METHODS
Bacterial Stains
A collection of 60 clinical P. aeruginosa strains was used in this
study. The clinical isolates were isolated from blood sample taken
between October 2011 andMay 2014. All patients were treated in
the Pediatric Hospital at Centro Medico Nacional, Siglo XXI in
Mexico City. The project was approved by the Ethics Committee
(No. R-2014-3603-44) of the Pediatric Hospital at the Centro
Medico Nacional, Instituto Mexicano del Seguro Social. In all
cases, the parents or guardians were informed about the nature
of the study and were asked to sign a consent form.
The following reference strains were used as positive controls:
P. aeruginosa PA14 strain, which is an isolate from burn
(Berkeley, California, USA) (Lee et al., 2006); two strains from
P. aeruginosa clone C: C strain, is a typical CF isolate (Hannover
Medical School, Germany) and SG17M strain, an environmental
isolate from a river water in the city of Mulheim, Germany
(Römling et al., 1994, 1997; Lee et al., 2014); P. aeruginosa PAO1
strain, which is an isolate from wound (Melbourne, Australia)
(Holloway, 1955; Lee et al., 2006). All the strains were maintained
in 15% glycerol at −70◦C. Each strain was biochemically typed
using conventional biochemical tests (Murray et al., 1995; Mac
Faddin, 2000) and the API20 NE system (Identification system
for non-enteric Gram-negative rods. bioMérieux, Inc.).
Virulence Genes and Type III Secretion
System Genotype (TTSS) Detection
Chromosomal DNA was isolated from overnight cultures in
Luria broth (Invitrogen, Carlsbad, Ca. USA), of each of the 60
clinical P. aeruginosa isolates, as well as from the P. aeruginosa
control strains (PA14, PAO1, C, and SG17M). DNA was purified
from bacteria byminiprep (DNeasy Blood&Tissue Kit QIAGEN,
Hilden, Germany) according to the manufacturer’s instructions.
All DNAs were adjusted to 100 ng/µl at 260/280 nm, using a
Tecan Genios equipment. Seven virulence genes (toxA, lasB, lecA,
algR, plcH, phzA1, and toxR) from P. aeruginosa were selected
and amplified by PCR using Taq DNA polymerase recombinant
(Invitrogen, Carlsbad, Ca. USA) and specific primers (Morales-
Espinosa et al., 2012). The type III secretion system genes
(exoS, exoT, and exoU) were investigated by PCR. The primers:
forward 5′ ACTCGTGCGTCCCTTCGTG 3′ and reverse 5′
GATACTCTGCTGACCTCGCTCTC 3′ were used for exoS and
exoT amplification. The conditions for thermal cycling were:
an initial denaturation cycle at 94◦C for 2 min, followed by 30
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FIGURE 1 | Restriction Patterns created with HinfI enzyme from PCR
products of exoT and exoS genes. DNA ladder of 100 bp (Invitrogen by
Thermo Fisher Scientific, Inc.) and 50 bp (Thermo Fisher Scientific, Inc.) (lines 1
and 8, respectively). PCR products from P. aeruginosa PA14 strain, PAO1
strain and a 1208 clinical strain, the primers: forward 5′
ACTCGTGCGTCCCTTCGTG 3′ and reverse 5′
GATACTCTGCTGACCTCGCTCTC 3′ were used (lines 2, 4, and 6,
respectively). Restriction pattern from PA14 strain product, which gave a
restriction pattern of two bands for the exoT gene: one of 292 bp and the
other of 233 bp (line 3). Restriction pattern from PAO1 strain product, which
present both exoT and exoS genes, the bands size correspond to 86, 122,
140, 168, 29, and 233 bp (line 5). Restriction pattern from PCR product of one
of our strains, this strain only present the exoS gene, which produced a
pattern of four bands: 86, 122, 140, and 168 bp (line 7).
cycles at 94◦C for 1min, the annealing temperature was 55◦C
for 1 min and 72◦C for 1min with a final cycle of 72◦C for
2min. Subsequently, a restriction pattern from the PCR product
was created with the Hinf I (Promega Life Science, Madison,
Wisconsin. USA) enzyme. The PA14 strain was used as a positive
control for exoT, which gave a two bands restriction pattern:
one of 292 bp and the other of 233 bp. The PAO1 strain
was used as positive control for both exoS and exoT genes,
which produced six bands: 86, 122, 140, 168, 233 and 292 bp
(Figure 1). The exoU gene was detected by PCR using the primers
previously documented by Morales-Espinosa (Morales-Espinosa
et al., 2012). Detection of the type IV pili (TFP) alleles was
carried out according to Kus’ characterization (Kus et al., 2004),
in which P. aeruginosa TFP are divided into five phylogenetic
groups. The complete characterization of TFP alleles was made
by sequencing (Sanger method, Macrogene Metagenome Next
Generation Sequencing [NGS] Service. Korea) of the PCR
products from two strains (1,207 and 1,242), which give a
greater PCR product (Genbank accession number KX096875 and
KX096876).
Frequency and Content of Genomic Islands
PCR protocols to amplify each gene belonging to PAGI-1 (ORF3,
ORF18, and ORF42), PAGI-2 (C22 and C105), PAGI-3 (SG8
and SG100), PAGI-4 (CL22), pKLC102 (CP10, CP44, and CP97),
PAPI-1 (the island was detected in its circular form or integrated
into the chromosome), and PAPI-2 (xerC, RS07-RS08, exoU)
were carried out according to authors’ instructions (Pronovost
et al., 2006; Qiu et al., 2006; Klockgether et al., 2007; Morales-
Espinosa et al., 2012).
PFGE (Pulse-Field Gel Electrophoresis)
Analysis
Genomic DNA in agarose blocks was prepared using the
method previously described by Liu (Liu et al., 1993) with
some modifications such as: allowing a bacterial growth of
no more than 12 h, subjecting the bacterial package to lysis
twice, deproteinizing the DNA-plugs twice and increasing the
number of washes (8) of the DNA-plugs with TBE buffer. The
SpeI (Roche Diagnostic GmbH. Mannheim, Germany) enzyme
was used to obtain the chromosomal profiles. SpeI fragments
were separated by a CHEF-DR II device (Bio-Rad, USA) and
electrophoresis was performed on 1.2 % agarose gels and 0.5X
TBE (45 mM Tris, 45 mM Boric acid, 1 mM EDTA) buffer at
10◦C with pulse time ramped from 5 to 25 s over 19 h and 5.3
V/cm and a second block with pulse time ramped from 5 to
60 s over 17 h and 5.3 V/cm. The sizes of SpeI fragments were
estimated using XbaI (Roche Diagnostic GmbH. Mannheim,
Germany) fragments of Salmonella Braenderup global standard
H9812. The images were digitized by the Gel Logic 112 imaging
system (Kodak, NY, USA). The fingerprinting profile in the
PFGE gel was analyzed using BioNumerics v.7.1 (Applied Maths,
Belgium) software package. After background subtraction and
gel normalization, typing of fingerprint profiles was carried
out based on banding similarity and dissimilarity, using the
Dice similarity coefficient (Dice, 1945) and the Unweighted
Pair Group Method with Arithmetic Mean (UPGMA; Day and
Edelsbrunner, 1984) according to average linkage clustering
methods.
MLST (Multilocus Sequence Typing)
Genotype
MLST was created according to the MLST scheme for P.
aeruginosa (http://pubmlst.org/paeruginosa) with some
modification to the annealing temperatures (according to
each specific primer set): acsA (64◦C), aroE (62.3◦C), guaA
(64.1◦C), mutL (65◦C), nuoD (56.5◦C), ppsA (64◦C), and trpE
(63.3◦C).
Antimicrobial Susceptibility
To assess the isolates antimicrobial susceptibility, the agar
dilution method was used according to the criteria of the Clinical
and Laboratory Standards Institute, using the recommended
media (CLSI, 2016). ATCC 27853 Pseudomonas aeruginosa,
ATCC 25922 Escherichia coli, ATCC 35218 E. coli, ATCC
29213 Staphylococcus aureus, and ATCC 29212 Enterococcus
faecalis were used as quality control. Susceptibility was tested
for the following antimicrobial: carbenicillin (Invitrogen Inc.,
CA, USA); ticarcillin (GlaxoSmithKline, Mexico); piperacillin
(Sigma-Aldrich Inc. MO, USA); ticarcillin/clavulanic acid
(GlaxoSmithKline, Mexico); piperacillin/tazobactam (Sigma-
Aldrich Inc. MO, USA); ceftazidime (Laboratorios Salus S. A.
de C. V. Mexico); ceftriaxone (Laboratorios Salus S. A. de
C. V. Mexico); cefotaxime (Laboratorios Salus S. A. de C. V.
Mexico); cefepime (Laboratorios Salus S. A. de C. V. Mexico);
Frontiers in Microbiology | www.frontiersin.org 3 March 2017 | Volume 8 | Article 313
Morales-Espinosa et al. Pseudomonas aeruginosa Strains Associated with Bacteremia
TABLE 1 | Genomic islands detection and susceptibility profile in P. aeruginosa strains associated to fatality cases in children with bacteremia.
Strain Child
gender/age
Underlying
conditions
20 antimicrobials tested GEIs detected
S I R
1197 Male/8 years Acute lymphoblastic
leukemia
TI, PI, TM, PT, CA, FE, IM,
AZ, AM, GE, TO, PO, CI,
LO, NO, LE
CB, CT, ME CR PAGI-1, PAPI-1,
PAPI-2,
pKLC102 [2]
1210 Female/1 year Hemophagocytic
syndrome
IM, ME, AM, GE, TO, PO,
CI, LO, NO, LE
CB, TI, TM, CA, FE, AZ PI, PT, CR, CT PAPI-1, PAPI-2 [8]
1211 Male/5 years Aplastic anemia TI, TM, CA, CR, FE, AZ, AM,
GE, TO, PO, CI, LO, NO, LE
CB, PI, CT PT, IM, ME PAPI-1, PAPI-2 [8]
1212 Female/14
years
Cavernous angioma TI, PI, TM, PT, CA, CR, CT,
FE, IM, ME, AZ, AM, GE,
TO, PO, CI, LO, NO, LE
CB PAPI-1, PAPI-2 [8]
1220 Male/4 years Osteosarcoma AM, GE, TO, PO, NO, LE CB, TI, PI, TM, CA, FE,
AZ, CI, LO
PT, CR, CT, IM, ME PAPI-1, PAPI-2,
pKLC102 [5]
1226 Male/1 year Biliary atresia PO, CI, LO, NO, LE TI CB, PI, TM, PT, CA, CR, CT,
FE, IM, ME, AZ, AM, GE, TO
PAPI-2 [11]
1239 Male/6 years Acute myeloblastic
leukemia
TI, FE, AZ, AM, GE, TO, PO,
NO
CB, PI, TM, PT, CA, CI,
LO, LE
CR, CT, IM, ME PAPI-1, PAPI-2 [8]
1241 Female/7 years Epoxy
encephalopathy
PO CB, TI, PI, TM, PT, CA, CR,
CT, FE, IM, ME, AZ, AM,
GE, TO, CI, LO, NO, LE
PAGI-1, PAPI-1,
PAPI-2 [4]
S, Susceptible; I, Intermediate resistance; R, Resistant. CB, Carbenicillin; TI, Ticarcillin; PI, Piperacillin; TM, Ticarcillin/Clavulanic acid; PT, Piperacillin/Tazobactam; CA, Ceftazidime; CR,
Ceftriaxone; CT, Cefotaxime; FE, Cefepime; IM, Imipenem; ME, Meropenem; AZ, Aztreonam; AM, Amikacin; GE, Gentamicin; TO, Tobramycin; PO, Polymyxin B; CI, Ciprofloxacin; LO,
Lomefloxacin; NO, Norfloxacin; LE, Levofloxacin. GEIs, Genomic Islands; [number] correspond to GEIs genotype.
imipenem (Ivax Pharmaceuticals Mexico, S. A. de C. V. Mexico);
meropenem (AstraZeneca, Mexico); aztreonam (Sigma-Aldrich
Inc., MO, USA); amikacin (Laboratorios Pisa S. A. de C. V.
Mexico); gentamicin (Sigma-Aldrich Inc.MO, USA); tobramycin
(Alcon Laboratorios S. A. de C. V. Mexico); polymyxin B
(GlaxoSmithKline, Mexico); ciprofloxacin (Laboratorio Lemery,
S. A. de C. V. Mexico); lomefloxacin (Sigma-Aldrich Inc. MO,
USA); norfloxacin (Productos Medix S. A de C. V. Mexico); and
levofloxacin (Laboratorio Lemery, S. A. de C. V. Mexico).
Acquired β-Lactamases Detection
The most common acquired β-lactamases (Kos et al., 2014;
Oliver et al., 2015) were searched for using PCR with specific
primers for each group (Table S1). The acquired β-lactamases
were sequenced (Macrogene Metagenome Next Generation
Sequencing [NGS] Service. Korea) in order to determine
the allele type. The conditions for thermal cycling for the
β-lactamases genes were: an initial denaturation cycle at 94◦C
for 2 min, followed by 35 cycles at 94◦C for 1min, the annealing
temperature was according to each specific primer set (Table S1)
for 1min and 72◦C for 1min with a final cycle of 72◦C for 2min.
All PCR products of each gene were visualized on agarose gel.
RESULTS
We carried out the characterization of 60 P. aeruginosa isolates.
All isolates showed biochemical patterns of P. aeruginosa
(data not shown). The isolates were isolated from children,
of whom 65% were female and 35% male. The median
age of patients at the time of P. aeruginosa bacteremia
diagnosis was 5.5 years with a range of 1 month to 14
years and 8 months. All patients admitted to hospital had
underlying disease. The most common underlying diseases
were hematological and oncological disease (52%) including
acute lymphoblastic leukemia, non-Hodgkin lymphoma, solid
tumor, hemophagocytic syndrome, histiocytosis and aplastic
anemia, and prematurity (24%), other underlying diseases were
gastrointestinal malformations, congenital cardiopathy, Wiscott-
Aldrich disease, DandyWalker syndrome, Chiari’s malformation,
and nephrogenic and diabetes insipidus (Figure 2). Medical
records were unavailable for eight patients.
In 28 patients, bacteremia was related to a central catheter.
Bacteremia was present in 21 children after chemotherapy
treatment, with neutropenia and fever developing. The overall
case fatality associated with P. aeruginosa bacteremia was 13.3%
(8 of 60), who developed septic shock and multi-organ failure
(Table 1).
Frequency of Virulence Genes and TTSS
Genotype Detection
All of the isolates isolated from the study’s patients presented
the seven virulence genes that were amplified by PCR. Due
to the high identity between the exoT (GenBank accession
NC_008463.1) and exoS (GenBank accession NC_002516.2)
genes (>80%), we could not design specific primers for PCR to
amplify each gene. Therefore, we had to use a new strategy that
allowed us to differentiate between the detection of exoS and
exoT in each of our strains. The in silico analysis of restriction
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FIGURE 2 | Pulse-Field gel electrophoresis (PFGE) profile dendrogram and genetic and phenotypic characteristics of P. aeruginosa strains isolated
from children with bacteremia. The dendrogram was generated by Dice similarity coefficient (Dice, 1945) and UPGMA (Day and Edelsbrunner, 1984) clustering
methods by using PFGE images of SpeI digested genomic DNA. The scale bar shows the correlation coefficient (%). Underlying disease (Dx): PNET, primary
(Continued)
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FIGURE 2 | Continued
neuroectodermal tumor; BD-TEF, bronchopulmonary dysplasia-tracheoesophageal fistula; PDA, persistent ductus arteriosus; SGER, severe gastroesophageal reflux;
ALL, acute lymphoblastic leukemia; VSD, ventricular septal defect; BD, bronchopulmonary dysplasia; CAP, community acquired pneumonia; NDI, nephrogenic
diabetes insipidus; CKD, chronic kidney disease; TEF, tracheoesophageal fistula; AML, acute myeloid leukemia. Asterisk indicate a new ST, which has not been
assigned. MDR, Multi-Drug Resistant; MR Moderately Resistant; XDR Extensively drug Resistant. The pili alleles were obtained according to Kus’s characterization
(Kus et al., 2004), in which P. aeruginosa type IV pili are divided into five distinct phylogenetic groups. The GEIs genotype was assigned base on the
presence/absence of genomic island, 12 different GEIs genotypes were found (for details see Table S2, Supplementary Material). The resistance profile was formed by
a number and a letter: the number indicates how many antibiotics the strain was resistant to; the letters were assigned alphabetically to differentiate among the
antimicrobial combinations for which the strains were resistant (detailed information is shown in Table S3, Supplementary Material).
patterns of exoS and exoT showed that the enzyme Hinf I yielded
two different patterns between them. Based on this new strategy,
75% of the strains were exoS+ and 70% exoT+. Of all our
strains, 90% presented the exoU gene, which was detected by
PCR using specific primers. In general, the 67% of our strains
were exoS+/exoU+ genotype, 23% were exoS−/exoU+ and 10%
were exoS+/exoU−. The exoS−/exoU− genotype was not found
in our study population. Previous studies have reported (Oliver
et al., 2015; Peña et al., 2015) that the exoY and exoT genes
are present in all strains. Reason for which, we decided not to
detect the exoY gene in the present study. However, due to our
results where found that the 30% of the isolates are negative exoT,
now, it does appear necessary to characterize the exoY gene in
our population and to determine if also there are negative exoY
strains.
TFP Allele Characterization and GEIs
Detection
With respect to characterization by TFP alleles (Kus et al., 2004),
we found that all strains produced a single PCR product ranging
in size from ∼1.4 to 2.8 kb. Based on PCR product size analysis,
30 out of 60 strains gave a product size of 1,400 bp which was
similar to that of group II from the PAO1 reference strain. In
addition, three yielded a PCR product of 2,650 bp, as seen for
the PA14 control strain and these three strains were determined
to belong to group III; 24 strains gave a PCR product (2,800
bp) greater than the PA14 strain; and three strains yielded a
PCR product of 1,560 bp. To complete the characterization by
TFP allele of the 27 strains with different PCR product sizes,
individual PCRs were performed using specific primers for the
tfpOa, tfpOb, tfpY, and tfpZ accessory genes present between tRNA
and pilA (Kus et al., 2004). The results showed that 22 strains
amplified the tfpO gene (group I), of which seven strains were
subgroup Ia and 15 were subgroup Ib, while one strain (1,242
strain) could not be characterized according to Kus’s criteria
(Kus et al., 2004). Therefore, we selected this strain (1,242)
and another strain (1,207) with a 2,800 bp PCR product. Both
products were sequenced and analysis of the strain 1,207 showed
the presence of the pilin glycosylation gene tfpO adjacent to
pilA (GenBank accession number KX096875), confirming that
this strain belongs to group I. However, subgroup 1a or 1b
characterization using specific primers for each subgroup (Kus
et al., 2004) could not be achieved. Sequence analysis of strain
1,242 showed a novel accessory gene (IS1383), which encodes for
a transposase and a new variant of pilA gene (GenBank accession
number KX096876). The transposase gene has 100% similarity
to a transposase gene described in cyclohexylamine-degrading
Pseudomonas plecoglossicida NyZ12, while the new variant of
pilA gene presented high identity in its first 345-381 nucleotides
with the pilA gene of P. aeruginosa M1-G, K122-4, and B136-
33 strains. According to this result, we identified a new variant
of PilA protein and probably, a new TFP allele (Figure S1). We
wanted to know if more strains from our study presented the
transposase gene and in turn, the new allele. We could not find
more strains with this novel TFP allele in our population. We
were not been able to sequence the 1,560 bp products of three
strains despite three consecutive attempts. However, considering
the size of the PCR product, which was very similar to the
strain PAO1 Group II, we decided to characterize this pil region
according to its restriction patterns with HphI enzyme, using the
PAO1 strain as reference. The restriction pattern presented for
the three strains was the same, with two bands of ∼750 and 650
bp (data not shown). However, this pattern was very different to
that of the PAO1 strain (675, 425, 147, and 96 bp bands size) and
other strains from group II, which suggests greater variability in
this region and possibly, the presence of other alleles, as yet not
described.
With respect to the detection of genomic islands, we found 12
GEIs genotypes (Table S2), and at least one genomic island was
found in all of the strains. The most frequently detected genomic
island was PAPI-2 (100%), followed by PAPI-1 (55%), PAGI-1
(47%), and pKLC102 (23%). PAGI-2 was detected in only 3% of
the strains; the genomic islands PAGI-3 and PAGI-4 were not
detected at all in our study population. Themajority of the strains
had only two islands; just one strain presented up to five GEIs
(PAGI-1, PAGI-2, PAPI-1, PAPI-2, and pKLC102); in six strains
four GEIs were detected; in 15 strains 3 GEIs were found and 13
strains had one island only. The genetic content of each GEIs was
variable, as has been previously documented (Liang et al., 2001;
Klockgether et al., 2007; Morales-Espinosa et al., 2012).
PFGE and MLST Genotype
Using SpeI fragment patterns, we found 42 different restriction
patterns, of which 29 corresponded to 29 single isolates (unique
patterns) and 13 were shared by two or three isolates (Figure 2).
Strains 1,195 and 1,203 could not be typed with this method.
Although, there were 13 strains that shared chromosomal
profiles, the majority of the strains were isolated from unrelated
patients, in different hospital services and on different dates.
In addition, each strain showed a variable number of GEIs or
variability in genetic content and/or a different antimicrobial
resistance profile. Only four strains (1,240, 1,250, 1,251, and
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1,252) presented the same or similar PFGE patterns and were
isolated from same patient in the same day. However, all the
isolates had different GEIs number with genetic content and
different resistant profile, indicating that this patient had a mixed
infection.
The sequence type (ST) in our strains was highly variable,
and showed a good correlation with the variability found using
the PFGE method. The most frequently detected ST was ST309,
which was present in nine strains. These strains were grouped
in only one cluster (Figure 2) and all of them shared the TFP
group II, six of out nine strains were isolated of urine from
patients with urinary tract infection as primary infection, six had
the highest resistance profile to around 20 antimicrobials, and
four shared the same GEIs genotype. Additionally, there were
six strains from this group that presented up to three different β-
lactamases (GES20, OXA2, and KPC). A further 21 strains shared
STs: as ST796 (5 strains), ST112 (4 strains), ST1503, and ST1816
(3 strains for each), ST357, ST897, and ST664 (2 strains for each),
while the remaining 30 strains presented a unique sequence type
(Figure 2).
Antimicrobial Susceptibility Profile
With respect to susceptibility, only two strains were susceptible
to all 20 antimicrobials tested. The 92% of the strains
were susceptible to polymyxin B, and between 70 and 85%
were sensitive to quinolones, aminoglycosides, cefepime and
ceftazidime, while, from 45 to 67% were susceptible to β-lactam
antibiotics (Table S3). With respect to resistance, seven strains
were resistant to almost all the antimicrobials. The highest
rate of intermediate resistance and resistance was observed for
carbenicillin (73%) and ceftriaxone (75%). In general, 31.6% (21)
of the strains showed resistance to more than 10 antibiotics;
21.6% (13) of strains were multi-resistant more than five
antibiotics. We found 43 profiles (phenotypes) of resistance,
based on antimicrobials combination for which they were
resistant (Table S3).
Regarding adquired β-lactamases detection, 46.6% strains had
at least one β-lactamase, with the most frequent detected being
KPC (23 strains), followed by OXA-2 (13), GES-20, and GES-5
(9), while VIM-46 was detected in only one strain. Eleven strains
presented 2 or 3 β-lactamases, and the greatest concentrated and
highest number of adquired β-lactamase types detected was in the
ST309 strains.
Based on phenotype stratification for antimicrobial
susceptibility or resistance profiles (Magiorakos et al., 2012), 10%
were multi-drug resistant (MDR), 18% extensively drug-resistant
(XDR), 68% moderately resistant and only 3% were considered
susceptible (Figure 2).
Genetic and Phenotypic Characteristics of
P. aeruginosa Strains Associated to Case
Fatality
Total case fatality associated with P. aeruginosa bacteremia was
13.3% (8/60). All the children who died were above 1 year of age
and the majority of these patients were diagnosed with a hemato-
oncological disease (Table 1). All the children developed septic
shock and multi-organ failure. Characterization of the strains
showed genetic and phenotypic variability, with four strains
sharing chromosomal patterns (1,211, 1,212, 1,220, and 1,239)
between them (Table 1 and Figure 2).
DISCUSSION
European epidemiological surveillance programs show that
P. aeruginosa is one of the most frequently isolated Gram-
negative microorganisms from patients admitted to ICU (Pujol
and Limón, 2013). The most important risk factors leading
to development of nosocomial infections associated with P.
aeruginosa in patients are a long period of hospitalization, the
existence of a serious pre-existing condition and exposure to
invasive procedures (Fergie et al., 1994; Yetkin et al., 2006;
Yang et al., 2011). P. aeruginosa-associated infections have a
high mortality rate due to the presence of virulence factors in
the bacterium, innate and acquired multidrug resistance, and
immune impairment of the host (Fergie et al., 1994; Lyczak
et al., 2000; Corona-Nakamura et al., 2001; Thuong et al., 2003;
Poole, 2011). Different studies have shown that P. aeruginosa
is generally acquired from the hospital environment, person-to-
person contact, indirect transmission via contaminated hands,
through contaminated respiratory care equipment, catheters,
irrigating solutions, and from the use diluted antiseptics and
cleaning solutions (Corona-Nakamura et al., 2001; Thuong et al.,
2003; Yetkin et al., 2006). Generally, P. aeruginosa outbreaks
in hospitals are associated with clonally-related strains and
through cross transmission in immunocompromised patients
with underlying diseases, such as those with malignancies, burns,
and prematurity (Agodi et al., 2007; Zhang et al., 2012; Cies et al.,
2015). Although P. aeruginosa is considered an opportunistic
pathogen, it has several virulence factors. These are encoded
on plasmids or chromosomal genes, such as lasB (encoding for
elastase), toxA (exotoxin-A), pilA (type fimbrial precursor type
IV pilin), plcH (hemolytic phospholipase C precursor), phzA1
(phenazine biosynthesis protein), toxR (positive transcriptional
regulator of toxA transcription), lecA (lectin; Wick et al., 1990;
Walker et al., 1995; Rumbaugh et al., 1999; Woods, 2004; Shen
et al., 2006; Wolska and Szweda, 2009; Morita et al., 2015),
and four type III effectors: ExoU (phospholipase A2), ExoY
(adenylate cyclase), ExoS (ADP-ribosylates numerous proteins,
including members of the Ras protein family) and ExoT (a
type III cytotoxin that functions as an anti-internalization factor
with an N-terminal RhoGAP domain and a C-terminal ADP-
ribosyltransferase domain; Sun and Barbieri, 2003; Jia et al.,
2006; Cisz et al., 2008; Sun et al., 2012). These last two effectors
are closely related to each other and participate in inhibiting
phagocytic cells (neutrophil and macrophage function) and in
bacterial uptake by epithelial cells (Engel and Balachandran,
2009). The characterization of strains from our current study
showed the presence of all virulence genes in 100% of the strains,
indicating that these genes are present in the structural integrity
of the bacterial chromosome. Contrary to report by other authors
(Feltman et al., 2001; Engel and Balachandran, 2009; Oliver
et al., 2015; Peña et al., 2015), almost all our strains presented
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the exoU gene. Determination of the TTSS genotype showed
that a high percentage was exoS+/exoU+ genotype. However,
not all strains present the exoT gene. The presence of both
exoS and exoU genes has been associated with acute infection
in humans, such as bacteremia, and correlates with a worse
outcome in clinical infections, a higher bacterial burden and a
greater risk of death in mechanically ventilated patients (Feltman
et al., 2001; Engel and Balachandran, 2009; Peña et al., 2015).
While it is true that the results of the present study confirm
this important relationship, between the exoS+/exoU+ genotype
and bacteremia, the infections were resolved via antimicrobial
treatment, probably due to low resistance of most of our strains
to fluoroquinolones, aminoglycosides and ceftazidime, a third
generation cephalosporin indicated for the treatment of patients
who develop fever associated with neutropenia. On the other
hand, registered mortalities in our study were reduced. Analysis
of the results showed that there was no association between the
exoS+/exoU+ genotype and risk of death.
The characterization of TFP alleles in our strains show
diversity in TFP alleles to a greater extent than previously
documented (Kus et al., 2004). A novel TFP allele was detected
on the transposase accessory gene located between tRNA and
pilA, which has been documented in other Pseudomonas species.
A novel group of the pilAVI gene with low sequence identity
in its 3′ end to other pilA groups of different P. aeruginosa
strains was also detected. The analysis of PilAVI amino acid
sequence showed a homology between 31.4 and 42.6% with
respect to other groups of PilA (Figure S1). Although, we did
not have experimental evidence of the PilA expression, the
amino acids sequence is highly homologous in its first 127
aa to other sequences of PilA available in the databases, as
it is showed in Figure S1. Using the Swiss-model (homology
modeling) software, we obtained a virtual protein structure 100%
homologous to P. aeruginosa fimbrial protein in its first 125
amino acids (image not shown), although from 126 to 142
aa, no homology was found with respect to the C-terminal
region of the same PilA protein. Interestingly, we observed the
lack of the two-cysteine residues within of its disulfide-bonded
loop (DSL) region, which are involved in the disulfide bond
formation contributing to the pilin assembly into fibers and
its adhesive capacity (Harvey et al., 2009). The detection of
this novel allele supports the notion of horizontal transfer of
genes and recombination within homologous regions between
bacteria and the incorporation of novel DNA into one of the
hypervariable regions of the P. aeruginosa chromosome. The
singularity of the accessory gene (transposase) and pilAVI gene
confirmed Kus’s observations that each pilin type is stringently
associated with a specific accessory gene. Additionally, the
presence of the transposase gene immediately adjacent to the
tRNAthr gene confirms that a mechanism of bacteriophage-
mediated transduction was involved in the generation of the
new TFP allele. This is not surprising, since it is known that
tRNA genes are hotspots for bacteriophage integration, where
we detected greater genetic variability, as seen in the lack of
characterization of three of our strains. The characterization of
our strains isolated from the blood of children with bacteremia
showed the predominance of two TFP alleles (group I and II).
In her study, Kus reported a similar percentage of group I pilins
within environmental strains and pediatric CF isolates, while in
other human isolates, there appears to be an approximately equal
distribution of strains within pilin groups I, II, and III (Kus
et al., 2004). The characterization of different populations of P.
aeruginosa isolated from different sources is required in order to
determine if there is a correlation between the pilA allele and a
specificity niche.
In addition to virulence genes, the bacterium acquired
foreign DNA in combinations of specific blocks of genes that
contributed to virulence and/or adaptation to specific niches.
These strain-specific segments of the genome are found in limited
chromosomal locations, referred to as genomic islands (GEIs),
which are acquired by HGT (Ou et al., 2006; Boyd et al., 2008;
Juhas et al., 2009). Depending on their functions, they encode
for pathogenicity, symbiosis, fitness, metabolic, or resistance
traits (Hacker and Kaper, 2000; Dobrindt et al., 2004; Juhas
et al., 2009). A large number of GEIs in the P. aeruginosa
chromosome have been described, but these GEIs are found in
varying numbers in some strains and not in others (Schmidt et al.,
1996; Liang et al., 2001; Larbig et al., 2002). In the present study,
all the strains isolated from children diagnosed with bacteremia
possessed the PAPI-2 Island and more than half of them had
PAPI-1 with both islands presenting a mosaic structure. Most
of the PAPI-2 genes are related to mobility functions, including
integrase genes, transposase genes, one pseudogene, and portions
of insertion sequences in addition to the presence of seven ORFs
that correspond to hypothetical proteins of unknown function
(He et al., 2004). Interestingly, in the right end of PAPI-2
there are two genes that correspond to the exoU gene and its
chaperone spcU (He et al., 2004). As mentioned previously, exoU
encodes a type III effector (ExoU) that plays an important role
in pathogenesis. ExoU is a potent cytotoxin with phospholipase
A2 activity, which has been associated with the development of
septic shock in an animal model (Kurahashi et al., 1999). The
presence of exoU in almost all our strains isolated from blood
samples taken from patients with bacteremia corroborates the
data previously reported by Kurahashi. The presence of exoU
on PAPI-2 defines this island as a pathogenicity island and it
is very likely that the expression of ExoU for P. aeruginosa
strains facilitates the spread through tissues favoring the arrival
of bacteria to bloodstream (He et al., 2004; Kulasekara et al.,
2006). On the other hand, PAPI-1 genes are involved in adhesion
and/or motility, although, the majority of their genes encode
for hypothetical proteins, making this island unique (He et al.,
2004; Qiu et al., 2006; Carter et al., 2010; Harrison et al., 2010).
This island contains two pairs of two-component regulatory
systems, which through mutational analysis have been shown to
affect plant and mammalian pathogenesis (He et al., 2004). In
addition to all genes being involved in type 4 fimbrial assembly
and function in the pil chromosomal region, the PAPI-I Island
has a set of genes (pilL, pilN, pilO, pilQ, pilR, pilS, pilT, pilV,
and pilM) involved in type IVb pilus biogenesis that contributes
to adherence onto synthetic surfaces, such as catheters (Giltner
et al., 2011), which provide an entrance to the circulatory system.
The presence of both PAPI-I and PAPI-2 islands in more
than half of our strains show that these islands are contributing
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to P. aeruginosa virulence, promoting colonization on catheter
surfaces and skin injury with the induction of proinflammatory
mediators, and passing the bacteria into the blood system
benefitting the survival and fitness of the bacterium. The
antimicrobial resistance profiles showed that more than half of
our strains isolated from children had a moderate resistance
profile, which may provide some explanation as to the low
mortality rate reported in our study. The number of MDR
and XDR strains detected is still low in the present study
(Pediatric Hospital), nevertheless, continuous epidemiological
surveillance is necessary to monitor MDR and XDR strain
presence considering the continuous admission of patients to
different hospital services and horizontal genes transfer from
hospital microbiota to patient’s native microbiota. Analysis of
chromosomal profiles and MLST of the strains showed great
genetic variability among our population, indicating that there
is no clonal relationship. However, it is striking that in a
cluster of nine strains, six were isolated from urine and all nine
share the ST309, TFP allele (group II), and have the XDR (six
strains) or MDR (two strains) phenotype. There are reports of
P. aeruginosa high-risk clones circulating in hospitals worldwide,
which present specific genetic characteristics (ST111, ST235,
and ST175) linked to MDR or XDR phenotype (Cabot et al.,
2012; Mulet et al., 2013; Witney et al., 2014; Oliver et al., 2015;
Peña et al., 2015). The increasing prevalence of these clones
complicates the clinical landscape, limiting therapeutic options
and having significant impact on morbidity and mortality. The
presence in our population of strains ST309 linked to the MDR
or XDR phenotype, make them a potential high-risk clone, which
was not documented as such, previously. However, it is important
to highlight that in our study, this clone was not associated
with any of the mortality cases. Studies in other populations
and hospitals settings are recommended in order to determine
the presence of ST309 as part of a potential high risk clone, its
distribution throughout hospitals in Mexico and its importance
to the severity of the clinical outcome.
Based on the overall analysis of the results obtained in
this study, we found that the strains of P. aeruginosa causing
bacteremia in each child harbored exoU and exoS. This results
are support for the Berthelot’s observations (Berthelot et al.,
2003), who characterized genetically and phenotypically 92 P.
aeruginosa strains isolated from blood: where, they identified
four groups of strains (TTSS types) according to level of type
III protein secretion and kinetics of cytotoxicity. Additionally,
they made the detection of exoU and exoS genes by real-time
PCR. They found a strong correlation among exoU+ and exoS+
genotype and TTSS phenotype. They concluded that the most
of the bacteremic strains (80%) were strongly cytotoxic for
macrophages and that the ExoU-secreting isolates killed the
phagocytes more rapidly. Based on Berthelot’s study, we can
deduce that our strains being cytotoxic. It is likely that exoU
was acquired through horizontal transfer of PAPI-2 from one
strains to other. It also appears likely that the patients were
carrying the majority of the strains prior to hospital admission
and immunosuppression caused by underlying disease favored
the multiplication of microorganisms and adherence to catheter
surfaces. The presence of exoU on PAPI-2 island gives bacteria
the ability to disseminate into the circulation and produce
bacteremia, and in some cases the development of septic shock
(Engel and Balachandran, 2009).
We identified a reduce number of exogenous β-lactamases
among strains, with KPC β-lactamase being the most frequent.
However, the presence of a potential high-risk clone, ST309
with a MDR or XDR phenotype, circulating throughout of our
hospital could create a serious health problem.
Multiresistant bacteria serve as hosts for the multiple genetic
elements (genes, integrons, transposons, and plasmids) that
confer their antibiotic resistance phenotypes. This important
characteristic allows to the bacteria to be a “successful”
bacterial strain, which is an extremely effective vehicle for the
dissemination of any genetic element (s) for at least two reasons:
(a) all of the hosted resistance elements are transmitted vertically
(i.e., from mother to daughter cells) by virtue of the strain’s
spread and its increasing prevalence and (b) a successful strain
has multiple opportunities to act as a donor and to transfer
its resistance elements horizontally to other strains, species or
genera (Maatallah et al., 2011; Woodford et al., 2011). So that,
the identification of a successful multiresistant strain or clone
should receive prompt attention to avoid HGT of antimicrobial
resistance into bacterial populations, and its dissemination to
different hospitals and different regions.
Additionally a high-risk clone should have important
characteristics: (a) to be pathogenic (to have virulence factors);
(b) to have a resistance profile to at least three groups of
antibiotics (extensive drug resistance) and (c) to be present in
different places (Woodford et al., 2011). ST309 strains have
been documented in France, Australia, Malaysia and even Brazil,
which have been isolated from water and some clinical samples
such as bronchial lavage, blood, and urinary tract (P. aeruginosa
PubMLST website).
Despite the fact that the relative contributions of endogenous
and exogenous sources to P. aeruginosa acquisition are not well-
established. At this moment, we can assume that in our study
hospital, P. aeruginosa infections are not the result of epidemic
outbreaks, since the strains associated with infection were highly
variable and they were not acquired in the hospital setting.
CONCLUSIONS
To conclude, genetic and phenotypic characterization of 60
isolates of P. aeruginosa associated with blood infections in
children admitted to a highly specialized hospital in Mexico,
showed that the infections were caused by strains with great
diversity in their accessory genome. In the majority of the cases,
there was no cross-infection between patients associated with
a single clone. The P. aeruginosa strains isolated from blood
and involved in bacteremia were TFP allele group I and II, and
cytotoxic (exoU+ and exoS+). The results support the idea that
the presence of PAPI-I and PAPI-2 in the strains contributed
to greater virulence, which is associated with better adherence
and dissemination into the bloodstream leading to an increased
risk of septicemia. We identified the presence of ST309 strains
isolated from urinary tract, which possess virulence genes, an
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extensive drug resistance phenotype, important characteristics
that would contribute to make them a potential high-risk
clone.
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